Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue 1.4 Market Analysis by Type 1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Over-the-counter (OTC) Testing Kits 1.4.3 Prescription-based Testing Kits 1.5 Market by Application 1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026 1.5.2 Bacterial Infections 1.5.3 Fungal Infection 1.5.4 Virus Infection 1.5.5 Cardiovascular Infection 1.5.6 Gastrointestinal Infection 1.5.7 Sexually Transmitted Disease (STD) Infection 1.5.8 Central Nervous System Infection 1.5.9 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Infectious Disease Point of Care Diagnostics Market Perspective (2015-2026) 2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions 2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Share by Regions (2015-2020) 2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Infectious Disease Point of Care Diagnostics Market Growth Strategy 2.3.6 Primary Interviews with Key Infectious Disease Point of Care Diagnostics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Market Size 3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2015-2020) 3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2015-2020) 3.1.3 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio 3.2.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2019 3.3 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served 3.4 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service 3.5 Date of Enter into Infectious Disease Point of Care Diagnostics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020) 4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026) 5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application (2015-2026) 5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2015-2020) 6.2 Infectious Disease Point of Care Diagnostics Key Players in North America (2019-2020) 6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) 6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2015-2020) 7.2 Infectious Disease Point of Care Diagnostics Key Players in Europe (2019-2020) 7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) 7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 8 China 8.1 China Infectious Disease Point of Care Diagnostics Market Size (2015-2020) 8.2 Infectious Disease Point of Care Diagnostics Key Players in China (2019-2020) 8.3 China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) 8.4 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2015-2020) 9.2 Infectious Disease Point of Care Diagnostics Key Players in Japan (2019-2020) 9.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) 9.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2015-2020) 10.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) 10.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 11 India 11.1 India Infectious Disease Point of Care Diagnostics Market Size (2015-2020) 11.2 Infectious Disease Point of Care Diagnostics Key Players in India (2019-2020) 11.3 India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) 11.4 India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2015-2020) 12.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America (2019-2020) 12.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) 12.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Abbott 13.1.1 Abbott Company Details 13.1.2 Abbott Business Overview and Its Total Revenue 13.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction 13.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)) 13.1.5 Abbott Recent Development 13.2 Siemens 13.2.1 Siemens Company Details 13.2.2 Siemens Business Overview and Its Total Revenue 13.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction 13.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.2.5 Siemens Recent Development 13.3 GE Healthcare 13.3.1 GE Healthcare Company Details 13.3.2 GE Healthcare Business Overview and Its Total Revenue 13.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction 13.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.3.5 GE Healthcare Recent Development 13.4 Accriva 13.4.1 Accriva Company Details 13.4.2 Accriva Business Overview and Its Total Revenue 13.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction 13.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.4.5 Accriva Recent Development 13.5 Terumo 13.5.1 Terumo Company Details 13.5.2 Terumo Business Overview and Its Total Revenue 13.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction 13.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.5.5 Terumo Recent Development 13.6 BioMerieux 13.6.1 BioMerieux Company Details 13.6.2 BioMerieux Business Overview and Its Total Revenue 13.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction 13.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.6.5 BioMerieux Recent Development 13.7 Diasorin 13.7.1 Diasorin Company Details 13.7.2 Diasorin Business Overview and Its Total Revenue 13.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction 13.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.7.5 Diasorin Recent Development 13.8 Roche 13.8.1 Roche Company Details 13.8.2 Roche Business Overview and Its Total Revenue 13.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction 13.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.8.5 Roche Recent Development 13.9 Danaher Corporation 13.9.1 Danaher Corporation Company Details 13.9.2 Danaher Corporation Business Overview and Its Total Revenue 13.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction 13.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.9.5 Danaher Corporation Recent Development 13.10 BD 13.10.1 BD Company Details 13.10.2 BD Business Overview and Its Total Revenue 13.10.3 BD Infectious Disease Point of Care Diagnostics Introduction 13.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 13.10.5 BD Recent Development 13.11 Bio-Rad Laboratories 10.11.1 Bio-Rad Laboratories Company Details 10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue 10.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction 10.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.11.5 Bio-Rad Laboratories Recent Development 13.12 Cavidi 10.12.1 Cavidi Company Details 10.12.2 Cavidi Business Overview and Its Total Revenue 10.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction 10.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.12.5 Cavidi Recent Development 13.13 Cepheid 10.13.1 Cepheid Company Details 10.13.2 Cepheid Business Overview and Its Total Revenue 10.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction 10.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.13.5 Cepheid Recent Development 13.14 Diaxonhit 10.14.1 Diaxonhit Company Details 10.14.2 Diaxonhit Business Overview and Its Total Revenue 10.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction 10.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.14.5 Diaxonhit Recent Development 13.15 Eiken Chemical 10.15.1 Eiken Chemical Company Details 10.15.2 Eiken Chemical Business Overview and Its Total Revenue 10.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction 10.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.15.5 Eiken Chemical Recent Development 13.16 EMD Millipore 10.16.1 EMD Millipore Company Details 10.16.2 EMD Millipore Business Overview and Its Total Revenue 10.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction 10.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.16.5 EMD Millipore Recent Development 13.17 Epitope Diagnostic 10.17.1 Epitope Diagnostic Company Details 10.17.2 Epitope Diagnostic Business Overview and Its Total Revenue 10.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction 10.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.17.5 Epitope Diagnostic Recent Development 13.18 Euroimmun 10.18.1 Euroimmun Company Details 10.18.2 Euroimmun Business Overview and Its Total Revenue 10.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction 10.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.18.5 Euroimmun Recent Development 13.19 Gold Standard Diagnostics 10.19.1 Gold Standard Diagnostics Company Details 10.19.2 Gold Standard Diagnostics Business Overview and Its Total Revenue 10.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction 10.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.19.5 Gold Standard Diagnostics Recent Development 13.20 Hologic 10.20.1 Hologic Company Details 10.20.2 Hologic Business Overview and Its Total Revenue 10.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction 10.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.20.5 Hologic Recent Development 13.21 Immunetics 10.21.1 Immunetics Company Details 10.21.2 Immunetics Business Overview and Its Total Revenue 10.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction 10.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.21.5 Immunetics Recent Development 13.22 InBios International 10.22.1 InBios International Company Details 10.22.2 InBios International Business Overview and Its Total Revenue 10.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction 10.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) 10.22.5 InBios International Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Infectious Disease Point of Care Diagnostics Key Market Segments Table 2. Key Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue Table 3. Ranking of Global Top Infectious Disease Point of Care Diagnostics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Over-the-counter (OTC) Testing Kits Table 6. Key Players of Prescription-based Testing Kits Table 7. Global Infectious Disease Point of Care Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2015-2020) Table 11. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Infectious Disease Point of Care Diagnostics Market Growth Strategy Table 17. Main Points Interviewed from Key Infectious Disease Point of Care Diagnostics Players Table 18. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2015-2020) (Million US$) Table 19. Global Infectious Disease Point of Care Diagnostics Market Share by Players (2015-2020) Table 20. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019) Table 21. Global Infectious Disease Point of Care Diagnostics by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service Table 24. Date of Enter into Infectious Disease Point of Care Diagnostics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 27. Global Infectious Disease Point of Care Diagnostics Market Size Share by Type (2015-2020) Table 28. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2021-2026) Table 29. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2015-2020) Table 30. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 31. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2021-2026) Table 32. North America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$) Table 33. North America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020) Table 34. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 35. North America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020) Table 36. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 37. North America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020) Table 38. Europe Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020) Table 40. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 41. Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020) Table 42. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 43. Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020) Table 44. China Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$) Table 45. China Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020) Table 46. China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 47. China Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020) Table 48. China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 49. China Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020) Table 50. Japan Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020) Table 52. Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 53. Japan Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020) Table 54. Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 55. Japan Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020) Table 58. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020) Table 60. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020) Table 62. India Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$) Table 63. India Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020) Table 64. India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 65. India Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020) Table 66. India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 67. India Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020) Table 68. Central & South America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020) Table 70. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020) Table 72. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020) Table 74. Abbott Company Details Table 75. Abbott Business Overview Table 76. Abbott Product Table 77. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 78. Abbott Recent Development Table 79. Siemens Company Details Table 80. Siemens Business Overview Table 81. Siemens Product Table 82. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 83. Siemens Recent Development Table 84. GE Healthcare Company Details Table 85. GE Healthcare Business Overview Table 86. GE Healthcare Product Table 87. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 88. GE Healthcare Recent Development Table 89. Accriva Company Details Table 90. Accriva Business Overview Table 91. Accriva Product Table 92. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 93. Accriva Recent Development Table 94. Terumo Company Details Table 95. Terumo Business Overview Table 96. Terumo Product Table 97. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 98. Terumo Recent Development Table 99. BioMerieux Company Details Table 100. BioMerieux Business Overview Table 101. BioMerieux Product Table 102. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 103. BioMerieux Recent Development Table 104. Diasorin Company Details Table 105. Diasorin Business Overview Table 106. Diasorin Product Table 107. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 108. Diasorin Recent Development Table 109. Roche Business Overview Table 110. Roche Product Table 111. Roche Company Details Table 112. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 113. Roche Recent Development Table 114. Danaher Corporation Company Details Table 115. Danaher Corporation Business Overview Table 116. Danaher Corporation Product Table 117. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 118. Danaher Corporation Recent Development Table 119. BD Company Details Table 120. BD Business Overview Table 121. BD Product Table 122. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 123. BD Recent Development Table 124. Bio-Rad Laboratories Company Details Table 125. Bio-Rad Laboratories Business Overview Table 126. Bio-Rad Laboratories Product Table 127. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 128. Bio-Rad Laboratories Recent Development Table 129. Cavidi Company Details Table 130. Cavidi Business Overview Table 131. Cavidi Product Table 132. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 133. Cavidi Recent Development Table 134. Cepheid Company Details Table 135. Cepheid Business Overview Table 136. Cepheid Product Table 137. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 138. Cepheid Recent Development Table 139. Diaxonhit Company Details Table 140. Diaxonhit Business Overview Table 141. Diaxonhit Product Table 142. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 143. Diaxonhit Recent Development Table 144. Eiken Chemical Company Details Table 145. Eiken Chemical Business Overview Table 146. Eiken Chemical Product Table 147. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 148. Eiken Chemical Recent Development Table 149. EMD Millipore Company Details Table 150. EMD Millipore Business Overview Table 151. EMD Millipore Product Table 152. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 153. EMD Millipore Recent Development Table 154. Epitope Diagnostic Company Details Table 155. Epitope Diagnostic Business Overview Table 156. Epitope Diagnostic Product Table 157. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 158. Epitope Diagnostic Recent Development Table 159. Euroimmun Company Details Table 160. Euroimmun Business Overview Table 161. Euroimmun Product Table 162. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 163. Euroimmun Recent Development Table 164. Gold Standard Diagnostics Company Details Table 165. Gold Standard Diagnostics Business Overview Table 166. Gold Standard Diagnostics Product Table 167. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 168. Gold Standard Diagnostics Recent Development Table 169. Hologic Company Details Table 170. Hologic Business Overview Table 171. Hologic Product Table 172. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 173. Hologic Recent Development Table 174. Immunetics Company Details Table 175. Immunetics Business Overview Table 176. Immunetics Product Table 177. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 178. Immunetics Recent Development Table 179. InBios International Company Details Table 180. InBios International Business Overview Table 181. InBios International Product Table 182. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$) Table 183. InBios International Recent Development Table 184. Research Programs/Design for This Report Table 185. Key Data Information from Secondary Sources Table 186. Key Data Information from Primary Sources List of Figures Figure 1. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2020 VS 2026 Figure 2. Over-the-counter (OTC) Testing Kits Features Figure 3. Prescription-based Testing Kits Features Figure 4. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026 Figure 5. Bacterial Infections Case Studies Figure 6. Fungal Infection Case Studies Figure 7. Virus Infection Case Studies Figure 8. Cardiovascular Infection Case Studies Figure 9. Gastrointestinal Infection Case Studies Figure 10. Sexually Transmitted Disease (STD) Infection Case Studies Figure 11. Central Nervous System Infection Case Studies Figure 12. Other Case Studies Figure 13. Infectious Disease Point of Care Diagnostics Report Years Considered Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size YoY Growth 2015-2026 (US$ Million) Figure 15. Global Infectious Disease Point of Care Diagnostics Market Share by Regions: 2020 VS 2026 Figure 16. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026) Figure 17. Porter's Five Forces Analysis Figure 18. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2019 Figure 19. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019 Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2019 Figure 21. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 26. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Central & South America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 30. Siemens Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 32. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 34. Accriva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 36. Terumo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 38. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 40. Diasorin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 42. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 44. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 46. BD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 48. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 50. Cavidi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 52. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 54. Diaxonhit Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 56. Eiken Chemical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 58. EMD Millipore Total Revenue (US$ Million): 2019 Compared with 2018 Figure 59. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 60. Epitope Diagnostic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 61. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 62. Euroimmun Total Revenue (US$ Million): 2019 Compared with 2018 Figure 63. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 64. Gold Standard Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 65. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 66. Hologic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 67. Hologic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Abbott Siemens GE Healthcare Accriva Terumo BioMerieux Diasorin Roche Danaher Corporation BD Bio-Rad Laboratories Cavidi Cepheid Diaxonhit Eiken Chemical EMD Millipore Epitope Diagnostic Euroimmun Gold Standard Diagnostics Hologic Immunetics InBios International